Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence

被引:43
作者
Jatlow, Peter [1 ]
Toll, Benjamin A. [2 ]
Leary, Vanessa [2 ]
Krishnan-Sarin, Suchitra [3 ]
O'Malley, Stephanie S. [3 ]
机构
[1] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA
基金
美国国家卫生研究院;
关键词
Carbon monoxide (CO); Plasma cotinine; Self report; Smoking; Tobacco; Abstinence;
D O I
10.1016/j.drugalcdep.2008.05.013
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The clinical pharmacology of biochemical measures of nicotine exposure has been thoroughly reviewed with regard to usefulness and limitations in detecting abstinence from cigarette smoking. While plasma nicotine concentration measures only acute nicotine exposure, plasma, salivary, and urine cotinine concentrations reflect exposure over an extended period of time. Although, expired carbon monoxide (CO) is frequently used to confirm self reports, it has a relatively short half life, calling into question whether this measure might provide misleading information by exaggerating smoking cessation success rates. To examine this question, we analyzed expired CO, plasma cotinine and self report data collected in a clinical trial in which subjects (N=207) were randomly assigned to gain- or loss-framed messages for smoking cessation in combination with open label sustained-release bupropion (300 mg/day). In examining measurements collected at 6 weeks, 3 and 6 months, results showed that CO significantly overestimated abstinence rates as compared with cotinine, although the discrepancy was less at the later time points. These data suggest that while expired CO is a useful and well-established marker in certain contexts, when testing extended abstinence from smoking with non-nicotine medications, cotinine measurements should be preferred. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 38 条
[1]   Sustained-release bupropion smoking cessation in African Americans - A randomized controlled trial [J].
Ahluwalia, JS ;
Harris, KJ ;
Catley, D ;
Okuyemi, KS ;
Mayo, MS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04) :468-474
[2]   Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial [J].
Aubin, HJ ;
Lebargy, F ;
Berlin, I ;
Bidaut-Mazel, C ;
Chemali-Hudry, J ;
Lagrue, G .
ADDICTION, 2004, 99 (09) :1206-1218
[3]   PROGRAMMED THERAPEUTIC MESSAGES AS A SMOKING TREATMENT ADJUNCT - REDUCING THE IMPACT OF NEGATIVE AFFECT [J].
BRANDON, TH ;
COPELAND, AL ;
SAPER, ZL .
HEALTH PSYCHOLOGY, 1995, 14 (01) :41-47
[4]   Reliability and validity of a smoking timeline follow-back interview [J].
Brown, RA ;
Burgess, ES ;
Sales, SD ;
Evans, DM ;
Miller, IW .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 1998, 12 (02) :101-112
[5]   Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression [J].
Cox, LS ;
Patten, CA ;
Niaura, RS ;
Decker, PA ;
Rigotti, N ;
Sachs, DPL ;
Buist, AS ;
Hurt, RD .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (08) :828-834
[6]   A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees [J].
Dalsgaro, OJ ;
Hansen, NCG ;
Soes-Petersen, U ;
Evald, T ;
Hoegholm, A ;
Barber, J ;
Vestbo, J .
NICOTINE & TOBACCO RESEARCH, 2004, 6 (01) :55-+
[7]  
Fiore MC., 2000, TREATING TOBACCO USE
[8]   Detecting smoking following smoking cessation treatment [J].
Gariti, P ;
Alterman, AI ;
Ehrman, R ;
Mulvaney, FD ;
O'Brien, CP .
DRUG AND ALCOHOL DEPENDENCE, 2002, 65 (02) :191-196
[9]   Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial [J].
Gonzales, David ;
Rennard, Stephen I. ;
Nides, Mitchell ;
Oncken, Cheryl ;
Azoulay, Salomon ;
Billing, Clare B. ;
Watsky, Eric J. ;
Gong, Jason ;
Williams, Kathryn E. ;
Reeves, Karen R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :47-55
[10]   Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study [J].
Gonzales, DH ;
Nides, MA ;
Ferry, LH ;
Kustra, RP ;
Jamerson, BD ;
Segall, N ;
Herrero, LA ;
Krishen, A ;
Sweeney, A ;
Buaron, K ;
Metz, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) :438-444